Skip to main content
. 2024 May 30;12:e17446. doi: 10.7717/peerj.17446

Table 2. The main pharmacokinetic parameters of tramadol and O-desmethyl tramadol in group C and group D.

Parameters Tramadol O-desmethyl tramadol
Group C Group D Group D Group D
AUC(0−t) (µg/L h) 777.09 ± 232.62 1,647.49 ± 474.03** 1,172.61 ± 170.75 1,226.57 ± 111.61
AUC(0−∞) (µg/L h) 790.48 ± 226.30 1,652.18 ± 474.39** 1,175.84 ± 170.44 1,251.86 ± 103.71
t1/2z (h) 6.69 ± 5.14 2.74 ± 0.56 2.86 ± 0.71 4.06 ± 0.91*
Tmax (h) 1.60 ± 0.55 0.90 ± 0.65 1.20 ± 0.45 0.90 ± 0.65
Vz/F (L/kg) 306.53 ± 308.69 51.44 ± 19.09 72.54 ± 25.45 94.72 ± 26.39
CLz/F (L/h/kg) 27.53 ± 9.92 12.81 ± 3.14** 17.31 ± 2.60 16.07 ± 1.36
Cmax (µg/L) 245.83 ± 57.58 294.28 ± 85.18 292.40 ± 55.09 181.96 ± 65.78*

Notes.

Group C: Tramadol single-use group; Group D: Tramadol with crizotinib (multiple dose for 7 days).

*P < 0.05, **P < 0.01, ***P < 0.001 in comparison with the control group.

AUC
area under the blood concentration–time curve
t1/2z
elimination half time
Tmax
peak time
Vz/F
apparent volume of distribution
CLz/F
blood clearance
Cmax
maximum blood concentration